High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.

@article{Alpay1999HighdoseII,
  title={High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.},
  author={Faruk Alpay},
  journal={Acta paediatrica},
  year={1999},
  volume={88 2},
  pages={216-9}
}
A controlled study was conducted to assess the role of high-dose i.v. immunoglobulin (HDIVIG) therapy in neonatal immune haemolytic jaundice. Patients with ABO and/or Rh incompatibilities proved by significant hyperbilirubinaemia (>204 mmol l(-1)), positive direct antiglobulin test and high reticulocyte count (> or =10%) were randomly assigned to receive either conventional phototherapy alone or phototherapy with high-dose i.v. immunoglobulin (1 g kg(-1), over 4 h) as soon as the diagnosis was… CONTINUE READING